Roadside saliva based testing for amphetamine-type stimulants in drivers: An evaluation of the relationship between positive drug tests and driving impairment after the consumption of methamphetamine and MDMA

自从维多利亚州对非法物质进行随机唾液测试以来，每48名被拦截的司机中就有一人对甲基苯丙胺呈阳性反应。由于安非他明被报道会增加道路碰撞风险，这一发现突显了一个重大的道路交通问题。拟议的研究将提供关于最准确的唾液药物测试的信息，以检测司机体内是否存在甲基苯丙胺和亚甲二氧基甲基安非他明，并提供与驾驶损伤有关的适当苯丙胺截止水平的数据。准确的毒品检测措施将使被苯丙胺损害的司机得到更好的检测，从而阻止司机在服用安非他明后驾车。

Since the implementation of random saliva tests for illicit substances in Victoria, 1 in 48 drivers intercepted have tested positive to the presence of methamphetamine. Because amphetamines have been reported to increase road crash risk, this finding highlights a significant road traffic problem. The proposed research will provide information on the most accurate saliva drug test to detect the presence of methamphetamine and MDMA in drivers, and will also provide data on the appropriate amphetamine cut-off level that relates to driving impairment. Accurate drug detection measures will result in better detection of drivers impaired by amphetamines, and in turn deter drivers from driving after consuming amphetamines.